H-ILLWQPIPV-OH

Ref. 3D-PP49265

Informations sur le produit

• Nom: H-ILLWQPIPV-OH

Description

Peptide H-ILLWQPIPV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ILLWQPIPV-OH include the following: A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic PL Vu, J Vadakekolathu , S Idri, H Nicholls - Cancers, 2022 - mdpi.comhttps://www.mdpi.com/2072-6694/14/8/1970 DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer JT Becker , BM Olson, LE Johnson - Journal of , 2010 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2010/07000/DNA_Vaccine_Encoding_Prostatic_Acid_Phosphatase.9.aspx Immunogenicity of MHC class I peptides derived from Leishmania mexicana Gp63 in HLA-A2. 1 transgenic (HHDII) and BALB/C mouse models H Rezvan , R Rees, SA Ali - Iranian journal of parasitology, 2012 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537470/ Defining T cell receptor repertoires using nanovial-based binding and functional screening D Koo , Z Mao , R Dimatteo , M Noguchi - Proceedings of the , 2024 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2320442121 Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice A Machlenkin, R Azriel-Rosenfeld , I Volovitz - Cancer Immunology , 2007 - Springerhttps://link.springer.com/article/10.1007/s00262-006-0184-0 Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy A Machlenkin, A Paz, E Bar Haim , O Goldberger - Cancer research, 2005 - AACRhttps://aacrjournals.org/cancerres/article-abstract/65/14/6435/518113

• Marque: Biosynth